Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0359 in Adult Patients With Chronic Asthma
NCT00482898Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0359 in asthma, sponsored by Merck & Co.. Started Sep 2002; status: completed.
02
Drugs
MK-0359
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00482898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482898.